SYGETIN BASED PHARMACEUTICAL COMPOSITION Russian patent published in 2009 - IPC A61K31/185 A61K31/197 A61K31/20 A61K47/26 

FIELD: medicine; pharmacology.

SUBSTANCE: pharmaceutical compositions for oral medical products are applied for prevention and treatment of menopausal disorders, postovariectomy syndrome, specifically to solid medicinal forms of Sygetin preparation. Offered pharmaceutical composition for prevention and treatment of menopausal disorders, contains Sygetin as active substance, disintegrating agent, antifriction substance and excipient, characterised that in addition it contains folic acid in ratio as follows (wt %): Sygetin - 3.0-80.0; folic acid - 0.04-0.4; disintegrating agent - 2.0-40.0; antifriction substance - 0.2-10.0; excipient - the rest.

EFFECT: reduced risk of cardiovascular diseases, reduced cardiologic risk and stroke risk, reduced risk of high blood pressure, reduced menopausal degenerative changes of skin and mucous membranes, reduced rate of breast cancer, rectal and large intestine cancer, endometrium cancer, urinary bladder cancer, larynx cancer, improved gastrointestinal tract activity, immunity strengthening, delayed menopause with relieved symptoms.

6 ex